Login   |  Users Online: 938 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Search Article 
  
Advanced search 
   Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts


 
  Table of Contents  
PHARMACOLOGICAL STUDY
Year : 2013  |  Volume : 34  |  Issue : 3  |  Page : 297-301  

Anti-inflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes


1 Ph. D Scholar, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
2 Professor, Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India

Date of Web Publication17-Dec-2013

Correspondence Address:
Yamini B Tripathi
Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-8520.123131

Rights and Permissions
   Abstract 

Changing life style and over-nutrition causes low-grade inflammation (LGI), with obesity and hyper-lipidemia as basic factors. The physiological state polarizes macrophages to classical type (M1), which is pro-inflammatory and promotes ectopic fat deposition in the body. Both factors induce inflammatory cascade, where free radicals (FRs) play an important role. Thus, pharmacological and non-pharmacological interventions would be effective in the management of LGI and plant products would be used as food supplement or as a drug. Previously, a study has reported the anti-oxidant potential of methanolic extract of tubers of Pueraria tuberosa (PTME) and inhibitory role of tuberosin on lipopolysaccharides-induced expression of inducible nitric oxide synthase in macrophages in an in vitro study model. Here, the effect of PTME has been explored on carrageenan-induced inflammatory changes in rats. The activity of antioxidant enzymes in red blood cell hemolysate has been assessed. PTME was orally given to rats for 9 days and periodical changes (every 3 rd day) in the activity/concentration of superoxide dismutase (SOD), catalase, reduced glutathione (GSH), lipid peroxides (LPO), and C-reactive proteins (CRP) were monitored. The PTME significantly prevented carrageenan-induced decline in GSH content, lowering of catalase and SOD activity, and rise in LPO and CRP in rats in a time-dependent, sequential manner. Thus, it could be suggested that the anti-inflammatory role of PTME is primarily mediated through its FR scavenging potential.

Keywords: Anti-inflammatory, anti-oxidant, Pueraria tuberosa


How to cite this article:
Pandey N, Yadav D, Pandey V, Tripathi YB. Anti-inflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes. AYU 2013;34:297-301

How to cite this URL:
Pandey N, Yadav D, Pandey V, Tripathi YB. Anti-inflammatory effect of Pueraria tuberosa extracts through improvement in activity of red blood cell anti-oxidant enzymes. AYU [serial online] 2013 [cited 2020 Apr 2];34:297-301. Available from: http://www.ayujournal.org/text.asp?2013/34/3/297/123131


   Introduction Top


The changing life style and improper dietary habits are the causes of several chronic metabolic diseases including metabolic syndrome. [1] The expanded adipose tissue and high immunological reactions in the body are some of the important factors. [2],[3] The low-grade inflammation (LGI) is also induced by hormonal imbalances, neurological hyper-stimulation, recurrent infections, autoimmune disorders, aging process, nutrition, life style, and environmental factors. A person with high caloric diet and western life styles are more prone to develop atherosclerosis, if pre-conditioned with LGI, involving various pathways e.g., oxidative stress and aberrant immune activity. [4],[5],[6] The excess accumulation of reactive oxygen species (ROS) has been reported to damage cellular macromolecules, leading to accumulation of lipid peroxides (LPO) or protein peroxides, [7] resulting to systemic LGI. Thus, pharmacological and non-pharmacological approaches, with multi-targeted action would be helpful in the management of atherosclerosis and diabetes and other associated complications. Here exploring the medicinal plants, to be used as food supplement would be beneficial.

The tubers of Pueraria tuberosa Linn (Fabaceae), (PT) are already used as medicine by Ayurvedic physicians for the management of fertility disorders, general weakness, and also as anti-ageing. [8] It is known as Bidarikand in Hindi and Indian Kudzu in English. Its various formulations are prescribed as nutritive, diuretic, expectorants, and for the management of rheumatism, fever, and bronchitis. Various in vitro experimental models earlier have established its anti-oxidant and anti-inflammatory property. [9],[10] Some of its other documented biological properties are anti-hyperglycemic, anti-hyperlipidemic, anti-fertility in male rats, and hepatoprotective. [11],[12],[13],[14] PT tubers are rich in isoflavonoids and terpenes with daidzein, puerarin, puetubersoanol, and tuberosin [15],[16] as bioactive phytochemicals.

However, its effect on in vivo model, especially against LGI has not been studied so far. Here, it is proposed to explore the effect of polar fraction of the tubers of Pueraria tuberosa Linn (Fabaceae), (PT) toward its anti-oxidant and anti-inflammatory potential, in an in vivo rat-model, where, carrageenan has been used to establish systemic LGI. [17] A correlation of anti-inflammatory properties with activity of anti-oxidant enzymes in red blood cell (RBC) (erythrocytes) has been explored.


   Materials and Methods Top


Materials

Carrageenan, trichloroacetic acid (TCA), nitroblue tetrazolium (NBT), sodium dodecyl sulfate (SDS), Riboflavin, were purchased from Hi Media, Mumbai, India. Other chemicals were of analytical grade. The experimental protocol was approved by the Institutional Animal Ethics committee of the Institute of Medical Sciences. (Dean/2011-12/208, dated 28-6-11).

Experimental design

The inbreed albino rats of Charles Foster strain were purchased from the central facility of our Institute. They were acclimatized in the institutional laboratory condition for a week and then randomly divided into three groups, having six animals in each. The 1 st Group was normal-control, where animals were kept on normal diet with drug vehicle only. The Group 2 was experimental control. Here, the animals received one dose of carrageenan through injection in the air-pouch (made on the back of each animal) and treated with drug vehicle. The extract-treated group was further divided into three sub-groups, where animals received different doses of Pueraria tuberosa (PTME) as 10 mg (3 rd Group), 20 mg (4 th Group), and 40 mg (5 th Group) per 100 g body weight. The treatment was continued for 9 consecutive days. From each animal, blood was collected on 3 rd , 6 th , and 9 th day of carrageenan administration and subjected to various biochemical tests as described below.

Estimation of lipid peroxides and C-reactive protein

The blood was collected in a plain tube and serum was separated. The degree of LPO was measured as thiobarbituric acid reactive substances (TBARS)/mg protein. [18] Here, 100 μl of serum was added to the reaction mixture (0.2 ml 10% SDS, 1.5 ml 0.8% TBA in water, 1.5 ml 20% acetic acid). It was mixed properly and heated in boiling water bath for 1 h. Finally, it was cooled and absorbance was read on 532 nm. Standard solution of tetra ethoxy propane (TEP) was used as a standard.

The C-reactive protein (CRP) was estimated by a commercially available kit (Hind diagnostic, Karaundi, Varanasi India). The 10 μl of serum (with different dilutions) was mixed with a drop of the given reagent, on a ceramic plate. That dilution point was recorded, which did not show any agglutination. It was calculated by multiplying dilution factor (D) with 0.6 and expressed as mg/ml. [19]

Assay of anti-oxidant enzymes

The blood was collected in a heparinized tube (0.5 ml) and RBC was separated after centrifugation. It was washed two times with phosphate buffer saline (PBS) and finally re-suspended in 2 ml of distilled water to prepare the hemolysate, which was used as the enzyme source. The hemoglobin (Hb) content was measured in this by Drabkin's, reagent. [20],[21]

The superoxide dismutase (SOD) activity was measured by the method of Beauchamp and Fridovich, as described earlier. [22],[23] Here, the instant superoxide-ions were generated by photoreaction using NBT (0.75 mM) in the presence of riboflavin. The reaction mixture was incubated with varying concentrations of hemolysate, (the source of SOD). The change in absorbance was read at 560 nm with reference to time. Thus, the kinetics of formation of blue-formazone, in presence of SOD indicated its activity, which was expressed as units/mg Hb). The 1 unit was defined as the amount of enzyme capable to inhibit formazone formation by 50%.

The catalase activity was assessed by method of Ashru and Sinha. [24] The reaction was initiated by adding H 2 O 2 ( 20 mM) to 500 μl of RBC hemolysate and after 1 min, 1 ml of 5% potassium dichromate-in acetic acid (3:1 ratio) was added. The absorbance was read at 620 nm and the activity was expressed as unit/mg Hb.

For measurement of reduced glutathione (GSH) content, 25 μl of fresh heparinized blood was immediately transferred to a tube containing 50 μl of metaphosphoric acid. It was mixed with 1 ml of precipitating reagent (0.5% m-phosphoric acid + 20 mM NaCl) and incubated for 20 min at room temperature. Finally, the reaction mixture was centrifuged at 2000 rpm. 800 μl of its supernatant was mixed with 200 ml of freshly prepared 5,5'- dithiobis-(2-nitrobenzoic acid) (DTNB) solution (in 0.03% sodium citrate, pH 6.8). Absorbance was taken at 412 nm and GSH content was reported as μg/mg of Hb.

All data were expressed as mean ± SD and Pearson's correlation analysis (SPSS 7.5 for Windows, SPSS Inc. IBM) was used to test the level of significance of correlation (Pandey et al., 2007).


   Observations and Results Top


Characterization of Pueraria tuberosa

The % yield of PTME was found to be 16.04%, which was calculated on the basis of weight of total raw material taken for extraction. The PTME showed the absence of proteins, proteinases and carbohydrates. It also failed to show any response on macrophages in relation to NO production, which indicated the absence of endotoxin in PTME. The content of tuberosin in PTME was found to be 11.5 mg/g of extract.

In vivo study of Pueraria tuberosa against carrageenan- induced changes in inflammatory markers in serum

In the experimental control group, the carrageenan injection did not raise the LPO and CRP content up to 6 th day. However on 9 th day, there was a significant increase in these parameters. In the PTME-treated group, significant inhibition was observed in the rise of LPO and CRP. The response was concentration-dependent [Table 1].
Table 1: Effect of methanolic extract of Pueraria tuberosa tubers on carrageenan induced thiobarbituric acid and C‑reactive proteins active substances

Click here to view


Effect of Pueraria tuberosa against carrageenan-induced changes in anti-oxidant enzymes in RBC

In the experimental control groups, carrageenan administration induced significant decline in GSH content on the 3 rd day, without any significant change in activity of catalase and SOD. On the 6 th day, the activities of both of these enzymes were significantly dropped. This low activity was also observed on the 9 th day. In contrast, PTME treatment significantly prevented these changes in a concentration-dependent manner [Table 2]. The fold change (calculated to normal value) in all the parameters on 9 th day, has also been presented in [Figure 1].
Figure 1: The fold change (calculated to normal value) in all the anti‑oxidant enzymes on 9th day

Click here to view
Table 2: Effect of methanolic extract of Pueraria tuberosa tubers on changes in carrageenan induced glutathione, catalase, and superoxide dismutase

Click here to view



   Discussion Top


Carrageenan is a high-molecular-weight sulfated polysaccharide. It produces an inflammation primarily by generating (1) excess free radicals (FRs), (2) release of histamine, serotonin, and bradykinin and also by (3) activation of toll-like receptor-4 receptors. [25] FRs further produce LPO, resulting in initiation of inflammation, which raises CRP in the blood and other disturbance in the homeostasis of the cell function. It also depletes glutathione content of the cell and inactivates various anti-oxidant enzymes. [26] Therefore, interruption at one of these steps, by using herbal products, could be an effective method for controlling these pathogenic processes. These results clearly indicate that PT extract reduces the CRP in the last days of treatment, showing its anti-inflammatory property. Interestingly, at this time point, TBARS was also raised, (9 th day), suggesting the role of FRs in the process, as lipid peroxidation is the end product oxidative stress. The FRs activate the expression of several inflammatory enzymes such as inducible nitric oxide synthase (iNOS), COX-2 etc., and cytokines, via activation of transcription factors like nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) and activator protein-1 (AP-1). [27] These inflammatory markers affect the liver to induce expression of acute phase proteins, e.g. CRP. This indicated that inflammation by carrageenan is a delayed process and there must be several steps involved upstream with these changing parameters.

It was earlier reported the inhibitory potential of PT extracts against lipopolysaccharides (LPS)-induced nitric oxide release in macrophages and inhibition of iNOS expression. [28] The tuberosin has been identified as the active principle, so the PTME has been standardized in terms of presence of tuberosin in PTME. It is a polyphenolic compound of flavones group. Besides its FR scavenging property, PTME also possesses metal chelation property. [10] These earlier reports support its observed anti-oxidant and anti-inflammatory potential.

Although there are several other metabolites in the blood, which act as FR trapper/scavenger, GSH plays a primary role. In the body, GSH is the 1 st line of defense against oxidative stress. It directly neutralizes the FRs and works in association with other anti-oxidants such as vitamin E/C. They help in recycling the oxidized glutathione disulfide (GSSG) to reduced GSH. [29] Thus, its reduction on 3 rd day is logical because of its continuous utilization in trapping the carrageenan-induced FRs. This is also supported by no rise in CRP and TBARS on 3 rd day.

However, the second line of protecting molecules is the anti-oxidant enzymes, [30] which are located in the RBC. The SOD is found to be very high in mitochondria, because it is the primary site for super oxide generation during electron transport chain for adenosine tri phosphate production. When superoxides (SO) are dismutated, they produce hydrogen peroxide, which may produce high level of hydroxyl radical (OH), if not decomposed. The OH is another highly active FR. Thus, catalase comes to work for hydrolyzing H 2 O 2 to water. Accordingly, the data show the decline in SOD and catalase activity on the 6 th day. There might be compensatory increase in these enzymes in early days, but persistent over-load of FRs might reduce their level on 6 th day. When all the protective tools in the system get exhausted, then lipid peroxidation is initiated by FRs. This has been observed by high TBARS and CRP on the 9 th day. Its late rise suggests the net effect of FR-mediated lipid peroxidation and related inflammation.

The treatment with PT extract prevented the rise in CRP on the 9 th day, which follows the rise in activity of SOD and catalase on the 6 th day. The GSH level was also raised on the 3 rd day. This reversal of anti-oxidant enzymes could be due to low FR stress in the blood. It could be because PTME directly traps the carrageenan-induced FRs and spares the use of GSH and other anti-oxidant enzymes from use. This logic is supported by our earlier report, [10] where it has been shown that PT is capable to trap all species of FRs along with metal chelation property [Figure 2]. However, the rise in catalase and SOD activity could be also due to their high expression at the transcriptional/translational level, but our existing data are not enough to answer this question.
Figure 2: Activities of antioxidant enzymes ‑ glutathione, superoxide dismutase, catalase and effect of Pueraria tuberosa on these enzymes

Click here to view






It can be concluded that the polar fraction of PT tuber (PTME) is rich in polyphenolic compounds. It traps the FRs and spares the use of GSH, catalase, and SOD in reducing FR stress. Its anti-inflammatory property (reported by low CRP and low TBARS) is primarily mediated through its FR scavenging potential, which is involved in the early steps of signal transduction in the process of inflammation.

 
   References Top

1.Theiss AL, Vijay-Kumar M, Obertone TS, Jones DP, Hansen JM, Gewirtz AT, et al. Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice. Gastroenterology 2009; 137:199-208.  Back to cited text no. 1
[PUBMED]    
2.Gremese E, Ferraccioli G. The metabolic syndrome: The crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 2011;10:582-9.  Back to cited text no. 2
[PUBMED]    
3.Hotamisligil GS. Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 2008;32:S52-4.  Back to cited text no. 3
[PUBMED]    
4.Innala L, Möller B, Ljung L, Magnusson S, Smedby T, Södergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: A five year prospective study. Arthritis Res Ther 2011;13:R131-40.  Back to cited text no. 4
    
5.Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.  Back to cited text no. 5
[PUBMED]    
6.Scarpellini E, Tack J. Obesity and metabolic syndrome: An inflammatory condition. Dig Dis 2012;30:148-53.  Back to cited text no. 6
[PUBMED]    
7.Tripathi YB. BHUx: A patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Recent Pat Inflamm Allergy Drug Discov 2009;3:49-57.  Back to cited text no. 7
[PUBMED]    
8.Pandey GS, Chunekar KC, Vidari K, editors. Bhav Prakash Nighantu. Vol. 1, Varanasi: Chaukambha Vidya Bhavan; 1998. p. 388-9.  Back to cited text no. 8
    
9.Tripathi YB, Nagwani S, Mishra P, Jha A, Rai SP. Protective effect of Pueraria tuberosa DC. embedded biscuit on cisplatin-induced nephrotoxicity in mice. J Nat Med 2012;66:109-18.  Back to cited text no. 9
[PUBMED]    
10.Pandey N, Chaurasia JK, Tiwari OP, Tripathi YB. Antioxidant properties of different fractions of tubers from Pueraria tuberosa Linn. Food Chem 2007;105:19-22.  Back to cited text no. 10
    
11.Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. J Nat Prod 2003;66:788-92.  Back to cited text no. 11
[PUBMED]    
12.Tanwar YS, Goyal S, Ramawat KG. Hypolipidemic effects of tubers of Indian Kudzu (Pueraria tuberosa). J Herb Med Toxicol 2008;2:21-5.  Back to cited text no. 12
    
13.Gupta RS, Sharma R, Sharma A. Antifertility effects of Pueraria tuberosa root extract in male rats. Pharm Biol 2004;42:3-9.  Back to cited text no. 13
    
14.Handa SS, Kaul MK. Recent development of some natural products. In: Handa SS, Kaul MK, editors. Supplement to Cultivation and Utilization of Medical Plants. Jammu-Tawi: CSIR, RPL; 1996. p. 53-96.  Back to cited text no. 14
    
15.Khan RA, Agarwal PK, Kapil RS. Puetuberosanol an epoxychalcanol from Pueraria tuberosa. Phytochemistry 1996;42:42-4.  Back to cited text no. 15
    
16.Joshi BS, Kamat VN. Tuberosin, a new pterocarpan from Pueraria tuberosa DC. J Chem Soc Perkin 1 1973;9:907-11.  Back to cited text no. 16
    
17.Oyanagui Y, Sato S, Okajima T. Suppressions of ischemic paw oedema in mice, rats and guinea pigs by superoxide dismutases from different sources. Free Radic Res Commun 1988;4:385-96.  Back to cited text no. 17
[PUBMED]    
18.Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.  Back to cited text no. 18
[PUBMED]    
19.Uhlin-Hansen L. C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels. Forensic Sci Int 2001;124:32-5.  Back to cited text no. 19
[PUBMED]    
20.Tiwari OP, Tripathi YB. Antioxidant properties of different fractions of Vitex negundo Linn. Food Chem 2005;100:70-6.  Back to cited text no. 20
    
21.Balasubramaniam P, Malathi A. Comparative study of hemoglobin estimated by Drabkin's and Sahli's methods. J Postgrad Med 1992; 38:8-9.  Back to cited text no. 21
[PUBMED]  Medknow Journal  
22.Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-87.  Back to cited text no. 22
[PUBMED]    
23.Chaurasia JK, Pandey N, Tripathi YB. Effect of hexane fraction of leaves of Cinnamomum tamala Linn on macrophage functions. Inflammopharmacology 2010;18:147-54.  Back to cited text no. 23
[PUBMED]    
24.A K, Sinha. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.  Back to cited text no. 24
    
25.He S, Liang Y, Shao F, Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A 2011;108:20054-9.  Back to cited text no. 25
[PUBMED]    
26.Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, et al. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996;118:829-38.  Back to cited text no. 26
[PUBMED]    
27.Chung JW, Kim JJ, Kim SJ. Antioxidative effects of cinnamomi cortex: A potential role of iNOS and COX-II. Pharmacogn Mag 2011;7:314-9.  Back to cited text no. 27
[PUBMED]    
28.Pandey N, Tripathi YB. Antioxidant activity of tuberosin isolated from Pueraria tuberose Linn. J Inflamm (Lond) 2010;7:47-54.  Back to cited text no. 28
    
29.Shaik IH, Mehvar R. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: Application to the rat liver and bile samples. Anal Bioanal Chem 2006;385:105-13.  Back to cited text no. 29
[PUBMED]    
30.Xiao GQ, Li HC. Effects of inhalation of oxygen on free radical metabolism and oxidative, antioxidative capabilities of the erythrocyte after intensive exercise. Res Sports Med 2006;14:107-15.  Back to cited text no. 30
[PUBMED]    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2]


This article has been cited by
1 Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets
Shivani Srivastava,Harsh Pandey,Surya Kumar Singh,Yamini Bhusan Tripathi
BioScience Trends. 2019;
[Pubmed] | [DOI]
2 Applications of Pueraria lobata in treating diabetics and reducing alcohol drinking
Jing Liu,Yeu-Ching Shi,David Yue-Wei Lee
Chinese Herbal Medicines. 2019;
[Pubmed] | [DOI]
3 Natural Products: Potential Source of DPP-IV Inhibitors
Rajeev K. Singla,Rishabh Kumar,Sameer Khan,Sameer Mohit,Kajal Kumari,Arun Garg
Current Protein & Peptide Science. 2019; 20(12): 1218
[Pubmed] | [DOI]
4 Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms
Vivek Kumar Gupta,Anupam Kaushik,Davendra Singh Chauhan,Ramesh Kumar Ahirwar,Shweta Sharma,Deepa Bisht
Journal of Ethnopharmacology. 2018; 227: 113
[Pubmed] | [DOI]
5 Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis
Shivani Srivastava,Priya Shree,Harsh Pandey,Yamini Bhusan Tripathi
Biomedicine & Pharmacotherapy. 2018; 97: 330
[Pubmed] | [DOI]
6 DPP-IV Inhibitory Potential of Methanolic Extract of Pueraria Tuberosa in Liver of Alloxan Induced Diabetic Model
Shivani Srivastava,Durgavati Yadav,Yamini Bhusan Tripathi
Biosciences Biotechnology Research Asia. 2018; 15(1): 01
[Pubmed] | [DOI]
7 Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats
Rashmi Shukla,Somanshu Banerjee,Yamini B. Tripathi
BMC Complementary and Alternative Medicine. 2018; 18(1)
[Pubmed] | [DOI]
8 An extract of Pueraria tuberosa tubers attenuates diabetic nephropathy by upregulating matrix metalloproteinase-9 expression in the kidney of diabetic rats
Yamini B. Tripathi,Rashmi Shukla,Nidhi Pandey,Vivek Pandey,Mohan Kumar
Journal of Diabetes. 2017; 9(2): 123
[Pubmed] | [DOI]
9 Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach
Shivani Srivastava,Priya Shree,Yamini Bhusan Tripathi
Journal of Diabetes & Metabolic Disorders. 2017; 16(1)
[Pubmed] | [DOI]
10 Pueraria tuberosa: a review on its phytochemical and therapeutic potential
Amal K. Maji,Subrata Pandit,Pratim Banerji,Debdulal Banerjee
Natural Product Research. 2014; : 1
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
    Materials and Me...
    Observations and...
   Discussion
   Conclusion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed2422    
    Printed58    
    Emailed0    
    PDF Downloaded461    
    Comments [Add]    
    Cited by others 10    

Recommend this journal